Revenue and net profit grew by 9.16% and 15.51% year-over-year in Q3 2024, with strong operating cash flow and significant increases in R&D and capital expenditures. Share buybacks and equity incentive adjustments were completed, and borrowings rose to support expansion.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.